DEPs including SAP, LTF, HSP90-α, AAT were enriched in these above-mentioned pathways, and were further screened out as candidate biomarkers for distinguishing AMS-susceptible individuals from AMS-resistant individuals. Here, SERPINA1 is linked to ablepharon macrostomia syndrome.